No Data
BioVie | 10-Q: Quarterly report
Express News | BioVie Awarded Up To $13.1M In Funding From US Department of Defense To Evaluate Bezisterim (NE3107) For Long COVID, The Study Is Expected To Start In Early 2025
Express News | BioVie Awarded up to $13.1 Million in Funding From U.S. Department of Defense to Evaluate Bezisterim (Ne3107) for the Treatment of Long Covid
BioVie Secures $13.1M Funding From US Department of Defense for Long COVID Treatment | NASDAQ:BIVI
BioVie Presents Data Showing Potential For Bezisterim To Reduce Inflammation And Restore Homeostasis In A Manner Correlated With Alzheimer's Disease And Biomarker Endpoints
"Bezisterim" has been approved as the non-proprietary name for NE3107Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammationCAR
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated With Alzheimer's Disease and Biomarker Endpoints
Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation
买跌不追涨 : 新冠病毒还没结束啊
TrytosaveabitOP 买跌不追涨: No! They just released information last week for companies to make modifications to their vaccines to combat new/mutated variant for this year! Grrrrrr
买跌不追涨 TrytosaveabitOP: 哎,没完没了了。其实如果这个病毒不再死人的话就当作感冒病毒好了
TrytosaveabitOP 买跌不追涨: If it’s a choice of being stuck with a MRNA vaccine or treat like a cold? Yes I’ll treat it like a cold! And that’s coming from someone who had it bad for almost 3 months until I could actually breathe halfway decent in January 22! Hehehe
买跌不追涨 TrytosaveabitOP: 啊,你还好吧?去进行治疗了吗?
View more comments...